Walder Wyss advised Allegria Therapeutics, a Basel-based biotech company developing therapies for mast cell-mediated diseases, throughout its USD 5.1 million seed extension funding round. The context ALK Abelló led the round in question, with support from
Antin Infrastructure Partners — a private equity firm with a focus on infrastructure — agreed to acquire NorthC, an enterprise colocation data center platform in Northwest Europe. In connection with the deal, which is expected to close
Walder Wyss advised SIX-listed positioning and wireless communication technologies specialist u-blox Holding as ZI Zenith – a European indirect subsidiary owned by investment funds managed or advised by Advent International – has completed its public tender offer
Walder Wyss advised Distalmotion, a globally active MedTech company based in Lausanne, throughout closing of its USD 150 million series G financing round. Revival Healthcare Capital led the funding round in question, with support from inside
Sedrun Solar – a project for a large-scale alpine photovoltaic plant in Switzerland – secured a syndicated project financing led by Zürcher Kantonalbank. In connection with the operation, Bratschi advised Sedrun Solar, while Walder Wyss represented
Bluu Unit – a portfolio company of Triton Smaller Mid-Cap Fund II active as a provider of sustainable refrigeration, air conditioning and heating technologies – completed the acquisition of IPS Gebäudetechnik, a specialist in the same
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.
Walder Wyss advised Valtronic Group, an electronics supplier specialised in developing, industrialising and manufacturing medical and diagnostic devices, on the sale of two subsidiaries with production sites in the US and Morocco to the Cicor
Walder Wyss advised Amag Leasing through placement of two senior green bond tranches in the amounting CHF 280,000,000. The bonds will be listed on the SIX Swiss Exchange. UBS Investment Bank, Zürcher Kantonalbank and
Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line
Legalcommunity.ch
Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).
For further information, please visit the Group’s website www.lcpublishinggroup.com
